China: The latest medtech access policies and implications

Published on August 8, 2023

The National Healthcare Security Administration (NHSA) has recently announced developments in the provincial medtech access and reimbursement policies. How will China’s medtech access landscape evolve as a result?

China has come a long way with pharmaceutical access policies since the introduction of the National Reimbursement Drug List (NRDL) system for innovative drugs in 2017, and volume-based procurement (VoBP) for matured generics in 2018. Despite tweaks and twists each year, the overarching framework has largely stayed intact and increasingly institutionalized.

The case is different for medtech.

New developments in China’s medtech access landscape

Historically the access environment, procurement process, coding eligibility, and reimbursement standards for medtech devices and consumables have always been region-specific. In many cases, there were substantial variations and…

Continue reading on website
Other news

Consumer streaming: Pricing to adapt to an evolving landscape

August 8, 2023
The streaming industry has undergone a remarkable transformation in recent years, impacting consumer habits and presenting significant challenges for streaming providers. As trends continue to shape the market, securing consumer loyalty becomes critical for companies seeking sustained growth. How can streaming providers effectively retain existing subscribers while attracting new ones in this comp

PPS Fall 2023 Pricing Workshops & Conference

August 8, 2023
Simon - Kucher is proud to be a platinum presenting sponsor at Professional Pricing Society's 34th annual Fall Conference. The 34th Annual Pricing Workshops & Conference to fill your revenue management toolbox will have session topics such as: omnichannel pricing, how to deal with your data, price increases amidst cooling inflation, AI’s sphere of influence, monetization, innovation, optimization,